The establishment of well-intentioned programs that fail to achieve their objectives and waste taxpayer dollars is an unfortunately frequent occurrence in the| Citizens Against Government Waste
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]| Citizens Against Government Waste
The federal 340B Drug Pricing Program was intended to provide discounts on drugs to patients but the lack of a clear intent and patient definition, along with| Citizens Against Government Waste
